ProKidney Corp. (PROK)
NASDAQ: PROK · IEX Real-Time Price · USD
2.110
-0.080 (-3.65%)
At close: Jul 19, 2024, 12:00 AM
2.140
+0.030 (1.42%)
Pre-market: Jul 22, 2024, 9:03 AM EDT

ProKidney Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Market Capitalization
6024191,597316-
Market Cap Growth
-85.86%-73.75%405.74%--
Enterprise Value
279611,109296-3
PE Ratio
--11.82-14.78-5.72-
PB Ratio
-0.34-0.38-1.4611.73-
P/FCF Ratio
-2.83-3.37-20.23-5.69-
P/OCF Ratio
-3.81-4.65-20.71-6.28-
EV/EBITDA Ratio
-2.01-2.36-10.67-5.580.12
EV/EBIT Ratio
-1.74-2.05-10.37-5.380.11
EV/FCF Ratio
-0.40-0.49-14.05-5.340.10
Debt / Equity Ratio
-0.010.000.000.050.16
Debt / EBITDA Ratio
-0.23-0.17-0.02-0.03-0.06
Debt / FCF Ratio
-0.04-0.04-0.03-0.02-0.05
Quick Ratio
17.0514.5045.091.670.83
Current Ratio
17.6214.9446.422.221.01
Interest Coverage
-2774.27-2455.00-497.31--
Return on Equity (ROE)
3.10%2.80%19.80%-1068.70%-
Return on Assets (ROA)
-8.10%-7.70%-31.90%-75.40%-
Return on Capital (ROIC)
13.83%13.79%13.98%-195.07%-236.58%
Earnings Yield
-5.86%-8.46%-6.77%-17.47%-
FCF Yield
-22.07%-29.65%-4.94%-17.58%-
Buyback Yield / Dilution
0.96%-0.28%59.17%-43.55%-
Total Shareholder Return
0.96%-0.28%59.17%-43.55%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).